Dapagliflozin maintains glycaemic control while reducing...

Diabetes, Obesity and Metabolism 2014 / 02 Vol. 16; Iss. 2

Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin

Bolinder, J., Ljunggren, Ö., Johansson, L., Wilding, J., Langkilde, A. M., Sjöström, C. D., Sugg, J., Parikh, S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
16
Language:
english
Journal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.12189
Date:
February, 2014
File:
PDF, 402 KB
english, 2014
Conversion to is in progress
Conversion to is failed